the presence of functional BAT, which appeared recruitable by cold acclimation. Molecular analysis confirmed the tissue specific expression of UCP1 in tenrecs (etUCP1). We cloned and stably transfected etUCP1 in HEK293 cells. Isolated mitochondria of etUCP1 HEK293 cells showed inducible proton conductance using palmitate, and GDP-sensitivity, similar to mitochondria containing mouse UCP1. For the search of functional differences, we established bioenergetic measurements in intact HEK293 cells using plate-based respirometry, allowing high-throughput approaches for small molecule modulators. In the initial experiments, we show that a cellpermeable UCP1 activator allows direct specific activation of tenrec and mouse UCP1.
The fruit-fly Drosophila melanogaster is widely used as a model organism to study human diseases, including those affecting mitochondria. Most mutant flies engineered to mimic mtDNA diseases die at the larval stages, yet a detailed bioenergetic characterization of developmental stage-specific features of Drosophila has never been carried out. We used muscular body-wall Drosophila larvae preparations to study respiration with the sensitive Seahorse â technology. This method allows us to study individual larvae and therefore whole tissue bioenergetics in situ. Larvae maintained a steady respiratory rate which was inhibited (i) by rotenone and antimycin A, demonstrating its mitochondrial origin and (ii) by 2-iodoacetate, suggesting that respiration is coupled to a high glycolytic flux. Unexpectedly, respiration could not be decreased by the F1FO ATPase inhibitor oligomycin nor increased by the uncoupler FCCP, suggesting that in Drosophila larvae mitochondria are uncoupled. Consistent with a developmental stage-specific uncoupling effect, the respiratory profile of embryonic multilineage Drosophila S2R + cells was instead essentially similar to that of mammalian cells in culture, as basal respiration could be inhibited by oligomycin and then stimulated by FCCP. Sequence homology analysis revealed the existence of four putative uncoupling proteins (UCPs) in Drosophila (UCP4a, UCP4b, UCP4c, and UCP5) that share 60-70% homology with their mammalian counterparts. Whether these are developmentally regulated is not known. We suspect that in the poikilotherm Drosophila uncoupling may be essential for thermogenesis in the pre-pupal stages. We are carrying out silencing of each UCP transcript in whole larvae, as well as genetic ablation of individual UCP genes, to address the potential role of UCP proteins in larval respiration. Since its discovery 15 years ago the transport function and the involvement of the inner mitochondrial membrane uncoupling protein 2 (UCP2) in diabetes, obesity, arteriosclerosis, neurodegenerative and neuroinflammatory diseases is controversially discussed. Moreover its tissue distribution is still uncertain, especially the presence of the protein in brain. Here, we re-evaluate the UCP2 expression pattern at mRNA and protein level and reveal a strong association of UCP2 with cells and tissues of the immune system, in particular with T-, B-, NK-cells and monocytes. Activation of T-cells leads to a 10-fold increase in UCP2 abundance. The late onset of UCP2 up-regulation in activated T-cells indicates a role of UCP2 in the later events of the immune response like metabolism increase and cell proliferation. We found only UCP4 (1, 2) and not UCP2 in neurons, although we confirmed the presence of UCP2 mRNA in brain. Instead, we detected UCP2 in microglia cells. Together with the reports from other research groups showing the presence of UCP2 in stem and cancer cells, our present results support the idea that UCP2 up-regulation is associated with the proliferative potential of cells. The biochemical activity of the uncoupling proteins (UCPs) is to lower the efficiency of the oxidative phosphorylation presumably by increasing the membrane proton conductance. This mild uncoupling would lead to an increase in respiration that should result in a lower generation of superoxide. This uncoupling activity has been proposed to constitute a mechanism of defence against oxidative stress and, in fact, it has been reported that UCPs are upregulated in physiological situations where there is oxidative stress and, furthermore, that their overexpression reduces ROS damage.
Tumour cells have a high intrinsic level of oxidative stress and, in these cells, UCP2 could play a defensive role [1] . Thus, it has been shown that in colon cancer UCP2 expression is increased and that Abstracts S44
